Not checkedNot checked for notices yet.
The efficacy of laser interstitial thermal therapy for brain metastases with in-field recurrence following SRS: systemic review and meta-analysis
Chao Chen, Yibin Guo, Yi Chen and 2 more
International Journal of Hyperthermia · 2021
doi:10.1080/02656736.2021.1889696 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Objective To study the efficacy of LITT for BM patients experiencing in-field recurrence following SRS. Methods A literature search was conducted to identify studies investigating local control (LC) rate and overall survival (OS) of LITT for BMs with IFR following SRS. Results Analysis included 14 studies (470 patients with 542 lesions). The 6-month (LC-6) and 12-month (LC-12) local control rates were 78.5% (95% CI: 70.6–84.8%) and 69.0% (95% CI: 60.0–76.7%) separately. Pooled median OS was 17.15 months (95% CI: 13.27–24.8). The overall OS-6 and OS-12 rates were 76.0% (95% CI: 71.4–80.0%) and 63.4% (95% CI: 52.9–72.7%) separately. LITT provided more favorable local control efficacy in RN than BM recurrence (LC-6: 87.4% vs. 67.9%, p = 0.009; LC-12: 76.3% vs. 59.9%, p = 0.041). Conclusions LITT is an effective treatment for BM patients experiencing IFR following SRS. For different pathological entities, LITT showed more satisfactory local control efficacy on RN than BM recurrence.
Abstract licence: CC BY-NC
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.